Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary escherichia coli from US outpatients

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 12, 2014, Pages 3259-3262

  Sanchez, G V ^a,b   Baird, A M G ^a,b   Karlowsky, J A ^c   Master, R N ^d   Bordon, J M ^e  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

^d QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^e Providence Hospital Washington DC   (United States)

Author keywords

Antibiotic resistance; Ciprofloxacin; Community; Guidelines; Primary care; Sulphonamides; Urinary tract infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; DISEASE SURVEILLANCE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT; PHENOTYPE; PREVALENCE; UNITED STATES; URINARY TRACT INFECTION; URINE CULTURE; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; NITROFURANTOIN; OUTPATIENTS; UNITED STATES; URINARY TRACT INFECTIONS;

EID: 84931082288     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku282     Document Type: Article

References (16)

1. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol 2010; 7:653-60.
2. Sanchez GV, Adams SJ, Baird AM et al. Escherichia coli antimicrobial resistance increased faster among geriatric outpatients compared with adult outpatients in the USA, 2000-10. J Antimicrob Chemother 2013; 68:1838-41.
3. Taur Y, Smith MA. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin Infect Dis 2007; 44:769-74.
4. Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103-20.
5. Shapiro DJ, Hicks LA, Pavia AT et al. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother 2014; 69:234-40.
6. Sahm DF, Brown NP, Yee YC et al. Stratified analysis of multidrugresistant Escherichia coli in US health care institutions. Postgrad Med 2008; 120:53-9.
7. Linhares I, Raposo T, Rodrigues A et al. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis 2013; 13:19.
8. Lagace-Wiens PR, Simner PJ, Forward KR et al. Analysis of 3789 in-and outpatient Escherichia coli isolates from across Canada-results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011; 69:314-9.
9. Karlowsky JA, Hoban DJ, Decorby MR et al. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob Agents Chemother 2006; 50:2251-4.
10. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999; 281:736-8.
11. Sanchez GV, Master RN, Karlowsky JA et al. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother 2012; 56:2181-3.
12. Pop-Vicas AE, D'Agata EM. The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital. Clin Infect Dis 2005; 40:1792-8.
13. Manges AR, Tabor H, Tellis P et al. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis 2008; 14:1575-83.
14. Johnson JR, Menard M, Johnston B et al. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009; 53:2733-9.
15. Karlowsky JA, Kasloff S, Nichol KA et al. Genetic relatedness of multidrugresistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimens. Diagn Microbiol Infect Dis 2007; 58:283-7.
16. Peirano G, Richardson D, Nigrin J et al. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-Β-lactamase-producing Escherichia coli isolates from Canada. Antimicrob Agents Chemother 2010; 54:1327-30.